Search Results - "Maurer, S."

Cardiac Amyloidosis: Overlooked, Underappreciated, and Treatable by Rubin, Jonah, Maurer, Mathew S

“…Cardiac amyloidosis (CA) is an infiltrative and restrictive cardiomyopathy that leads to heart failure, reduced quality of life, and death. The disease has two…”
Get full text

Addressing Common Questions Encountered in the Diagnosis and Management of Cardiac Amyloidosis by Maurer, Mathew S, Elliott, Perry, Comenzo, Raymond, Semigran, Marc, Rapezzi, Claudio

“…Advances in cardiac imaging have resulted in greater recognition of cardiac amyloidosis in everyday clinical practice, but the diagnosis continues to be made…”
Get full text

Noninvasive Identification of ATTRwt Cardiac Amyloid: The Re-emergence of Nuclear Cardiology by Maurer, Mathew S., MD

“…Abstract More than half of all subjects with chronic heart failure are older adults with preserved ejection fraction (HFpEF). Effective therapy for this…”
Get full text

Pathophysiology and Therapeutic Approaches to Cardiac Amyloidosis by Griffin, Jan M., Rosenblum, Hannah, Maurer, Mathew S.

“…Often considered a rare disease, cardiac amyloidosis is increasingly recognized by practicing clinicians. The increased rate of diagnosis is in part due the…”
Get full text

Cardiac Amyloidosis: Evolving Diagnosis and Management: A Scientific Statement From the American Heart Association by Kittleson, Michelle M., Maurer, Mathew S., Ambardekar, Amrut V., Bullock-Palmer, Renee P., Chang, Patricia P., Eisen, Howard J., Nair, Ajith P., Nativi-Nicolau, Jose, Ruberg, Frederick L.

“…Transthyretin amyloid cardiomyopathy (ATTR-CM) results in a restrictive cardiomyopathy caused by extracellular deposition of transthyretin, normally involved…”
Get full text

Diagnosis and treatment of cardiac amyloidosis: a position statement of the ESC Working Group on Myocardial and Pericardial Diseases by Garcia-Pavia, Pablo, Rapezzi, Claudio, Adler, Yehuda, Arad, Michael, Basso, Cristina, Brucato, Antonio, Burazor, Ivana, Caforio, Alida L P, Damy, Thibaud, Eriksson, Urs, Fontana, Marianna, Gillmore, Julian D, Gonzalez-Lopez, Esther, Grogan, Martha, Heymans, Stephane, Imazio, Massimo, Kindermann, Ingrid, Kristen, Arnt V, Maurer, Mathew S, Merlini, Giampaolo, Pantazis, Antonis, Pankuweit, Sabine, Rigopoulos, Angelos G, Linhart, Ales

“…Cardiac amyloidosis is a serious and progressive infiltrative disease that is caused by the deposition of amyloid fibrils at the cardiac level. It can be due…”
Get full text

Frailty Assessment in the Cardiovascular Care of Older Adults by Afilalo, Jonathan, MD, MSc, Alexander, Karen P., MD, Mack, Michael J., MD, Maurer, Mathew S., MD, Green, Philip, MD, Allen, Larry A., MD, MPH, Popma, Jeffrey J., MD, Ferrucci, Luigi, MD, PhD, Forman, Daniel E., MD

“…Due to the aging and increasingly complex nature of our patients, frailty has become a high-priority theme in cardiovascular medicine. Despite the recognition…”
Get full text

Transthyretin cardiac amyloidosis in continental Western Europe: an insight through the Transthyretin Amyloidosis Outcomes Survey (THAOS) by Damy, Thibaud, Kristen, Arnt V, Suhr, Ole B, Maurer, Mathew S, Planté-Bordeneuve, Violaine, Yu, Ching-Ray, Ong, Moh-Lim, Coelho, Teresa, Rapezzi, Claudio

“…Abstract Aims Transthyretin amyloidosis (ATTR amyloidosis) is a heterogeneous disorder with cardiac, neurologic, and mixed phenotypes. We describe the…”
Get full text

Expert Consensus Recommendations for the Suspicion and Diagnosis of Transthyretin Cardiac Amyloidosis by Maurer, Mathew S, Bokhari, Sabahat, Damy, Thibaud, Dorbala, Sharmila, Drachman, Brian M, Fontana, Marianna, Grogan, Martha, Kristen, Arnt V, Lousada, Isabelle, Nativi-Nicolau, Jose, Cristina Quarta, Candida, Rapezzi, Claudio, Ruberg, Frederick L, Witteles, Ronald, Merlini, Giampaolo

“…Cardiomyopathy is a manifestation of transthyretin amyloidosis (ATTR), which is an underrecognized systemic disease whereby the transthyretin protein misfolds…”
Get full text

Natural history and therapy of TTR-cardiac amyloidosis: emerging disease-modifying therapies from organ transplantation to stabilizer and silencer drugs by Castaño, Adam, Drachman, Brian M., Judge, Daniel, Maurer, Mathew S.

“…Transthyretin-cardiac amyloidoses (ATTR-CA) are an underdiagnosed but increasingly recognized cause of heart failure. Extracellular deposition of fibrillary…”
Get full text

Cost-Effectiveness of Tafamidis Therapy for Transthyretin Amyloid Cardiomyopathy by Kazi, Dhruv S., Bellows, Brandon K., Baron, Suzanne J., Shen, Changyu, Cohen, David J., Spertus, John A., Yeh, Robert W., Arnold, Suzanne V., Sperry, Brett W., Maurer, Mathew S., Shah, Sanjiv J.

“…BACKGROUND:In patients with transthyretin amyloid cardiomyopathy, tafamidis reduces all-cause mortality and cardiovascular hospitalizations and slows decline…”
Get full text

Prevalence and Prognostic Significance of Low QRS Voltage Among the Three Main Types of Cardiac Amyloidosis by Cyrille, Nicole B., MD, Goldsmith, Jeff, PhD, Alvarez, Julissa, MD, Maurer, Mathew S., MD

“…Low voltage is classically reported as an electrocardiographic (ECG) finding in cardiac amyloidosis (CA). We evaluated electrocardiograms to determine the…”
Get full text

Diagnosis and treatment of cardiac amyloidosis. A position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases by Garcia‐Pavia, Pablo, Rapezzi, Claudio, Adler, Yehuda, Arad, Michael, Basso, Cristina, Brucato, Antonio, Burazor, Ivana, Caforio, Alida L.P., Damy, Thibaud, Eriksson, Urs, Fontana, Marianna, Gillmore, Julian D., Gonzalez‐Lopez, Esther, Grogan, Martha, Heymans, Stephane, Imazio, Massimo, Kindermann, Ingrid, Kristen, Arnt V., Maurer, Mathew S., Merlini, Giampaolo, Pantazis, Antonis, Pankuweit, Sabine, Rigopoulos, Angelos G., Linhart, Ales

“…Cardiac amyloidosis is a serious and progressive infiltrative disease that is caused by the deposition of amyloid fibrils at the cardiac level. It can be due…”
Get full text

Transthyretin Stabilization by AG10 in Symptomatic Transthyretin Amyloid Cardiomyopathy by Judge, Daniel P., Heitner, Stephen B., Falk, Rodney H., Maurer, Mathew S., Shah, Sanjiv J., Witteles, Ronald M., Grogan, Martha, Selby, Van N., Jacoby, Daniel, Hanna, Mazen, Nativi-Nicolau, Jose, Patel, Jignesh, Rao, Satish, Sinha, Uma, Turtle, Cameron W., Fox, Jonathan C.

“…Transthyretin (TTR) amyloidosis is an underdiagnosed disease caused by destabilization of TTR due to pathogenic mutations or aging. Both pathogenic and…”
Get full text

Screening for ATTR amyloidosis in the clinic: overlapping disorders, misdiagnosis, and multiorgan awareness by Nativi-Nicolau, Jose N., Karam, Chafic, Khella, Sami, Maurer, Mathew S.

“…Amyloid transthyretin (ATTR) amyloidosis is a clinically heterogeneous and fatal disease that results from deposition of insoluble amyloid fibrils in various…”
Get full text

Polypharmacy in Older Adults Hospitalized for Heart Failure by Unlu, Ozan, Levitan, Emily B., Reshetnyak, Evgeniya, Kneifati-Hayek, Jerard, Diaz, Ivan, Archambault, Alexi, Chen, Ligong, Hanlon, Joseph T., Maurer, Mathew S., Safford, Monika M., Lachs, Mark S., Goyal, Parag

“…Despite potential harm that can result from polypharmacy, real-world data on polypharmacy in the setting of heart failure (HF) are limited. We sought to…”
Get full text

International External Validation Study of the 2014 European Society of Cardiology Guidelines on Sudden Cardiac Death Prevention in Hypertrophic Cardiomyopathy (EVIDENCE-HCM) by O’Mahony, Constantinos, Jichi, Fatima, Ommen, Steve R, Christiaans, Imke, Arbustini, Eloisa, Garcia-Pavia, Pablo, Cecchi, Franco, Olivotto, Iacopo, Kitaoka, Hiroaki, Gotsman, Israel, Carr-White, Gerald, Mogensen, Jens, Antoniades, Loizos, Mohiddin, Saidi A, Maurer, Mathew S, Tang, Hak Chiaw, Geske, Jeffrey B, Siontis, Konstantinos C, Mahmoud, Karim D, Vermeer, Alexa, Wilde, Arthur, Favalli, Valentina, Guttmann, Oliver P, Gallego-Delgado, Maria, Dominguez, Fernando, Tanini, Ilaria, Kubo, Toru, Keren, Andre, Bueser, Teofila, Waters, Sarah, Issa, Issa F, Malcolmson, James, Burns, Tom, Sekhri, Neha, Hoeger, Christopher W, Omar, Rumana Z, Elliott, Perry M

“…BACKGROUND:Identification of people with hypertrophic cardiomyopathy (HCM) who are at risk of sudden cardiac death (SCD) and require a prophylactic implantable…”
Get full text

Unveiling outcomes in coexisting severe aortic stenosis and transthyretin cardiac amyloidosis by Rosenblum, Hannah, Masri, Ahmad, Narotsky, David L., Goldsmith, Jeff, Hamid, Nadira, Hahn, Rebecca T., Kodali, Susheel, Vahl, Torsten, Nazif, Tamim, Khalique, Omar K., Bokhari, Sabahat, Soman, Prem, Cavalcante, João L., Maurer, Mathew S., Castaño, Adam

“…Aims Advances in diagnostic imaging have increased the recognition of coexisting transthyretin cardiac amyloidosis (ATTR‐CA) and severe aortic stenosis (AS),…”
Get full text

The Future for Patients With Transthyretin Cardiac Amyloidosis Is Looking Brighter by Patel, Jignesh K., Maurer, Mathew S.

Get full text

Screening for Cardiac Amyloidosis 5 to 15 Years After Surgery for Bilateral Carpal Tunnel Syndrome by Westin, Oscar, Fosbøl, Emil L., Maurer, Mathew S., Leicht, Birgitte P., Hasbak, Philip, Mylin, Anne Kærsgaard, Rørvig, Sara, Lindkær, Thomas Hartvig, Johannesen, Helle Hjorth, Gustafsson, Finn

“…Bilateral carpal tunnel syndrome (CTS) is a common extracardiac manifestation of amyloidosis and usually predates overt cardiac amyloidosis (CA) by several…”
Get full text